XTX Markets Portfolio holdings
XTX Markets's holdings are now reported by XTX Topco.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.82M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.16M |
| 3 |
Splunk
SPLK
|
+$829K |
| 4 |
Lockheed Martin
LMT
|
+$730K |
| 5 |
Mastercard
MA
|
+$557K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
L3Harris
LHX
|
+$665K |
| 2 |
KSU
Kansas City Southern
KSU
|
+$533K |
| 3 |
Marsh
MRSH
|
+$447K |
| 4 |
Union Pacific
UNP
|
+$432K |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$428K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.5% |
| 2 | Healthcare | 12.87% |
| 3 | Financials | 12.63% |
| 4 | Industrials | 10.75% |
| 5 | Communication Services | 10.47% |
Similar funds
XTX Markets's Q4 2020 Portfolio in Review
As of Q4 2020, XTX Markets held 277 positions worth $48.5M, up 133% from $20.8M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
XTX Markets deployed $24.1M of net new capital in Q4 2020, opening 178 new positions and adding to 6 existing holdings. Its largest new stake was Alphabet (Google) Class C: 21,540 shares worth $1.89M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ultragenyx Pharmaceutical, an estimated $202K trimmed.
- XTX Markets's largest Q4 2020 buy was Alphabet (Google) Class C: 21,540 shares worth $1.89M.
- XTX Markets added most to Ovid Therapeutics in Q4 2020, an estimated $84.2K increase.
- XTX Markets's biggest Q4 2020 reduction was Ultragenyx Pharmaceutical, cutting an estimated $202K.
- XTX Markets fully exited L3Harris in Q4 2020, selling an estimated $665K.
- XTX Markets's ten largest holdings make up 16% of its $48.5M portfolio in Q4 2020.
- XTX Markets opened 178 new positions and closed 85 in Q4 2020.
- XTX Markets's portfolio value rose 133% quarter-over-quarter to $48.5M.
Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.